Abstract
A 10-year old female on phenytoin therapy developed a rash and lymphadenopathy. H.p.l.c. assays of urinary metabolites indicated no differences in stereoselective metabolism of phenytoin to phenolic and dihydrodiol metabolites as compared with volunteers given the drug or with pediatric patients without adverse reactions. This suggests that no obvious difference in stereoselective metabolism of phenytoin to potentially toxic arene oxides exists between this patient and other patients on phenytoin. Our results are consistent with the hypothesis that differences in peripheral detoxication of phenytoin arene oxides and not differences in hepatic metabolism of phenytoin may be responsible for such adverse reactions.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dudley K. H., Bius D. L., Kraus B. L., Boyles L. W. Gas chromatographic on-column methylation technique for the simulataneous determination of antiepileptic drugs in blood. Epilepsia. 1977 Jun;18(2):259–276. doi: 10.1111/j.1528-1157.1977.tb04475.x. [DOI] [PubMed] [Google Scholar]
- Gerson W. T., Fine D. G., Spielberg S. P., Sensenbrenner L. L. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro. Blood. 1983 May;61(5):889–893. [PubMed] [Google Scholar]
- Jerina D. M., Daly J. W. Arene oxides: a new aspect of drug metabolism. Science. 1974 Aug 16;185(4151):573–582. doi: 10.1126/science.185.4151.573. [DOI] [PubMed] [Google Scholar]
- Maguire J. H., Kraus B. L., Butler T. C., Dudley K. H. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man. Ther Drug Monit. 1979;1(3):359–370. doi: 10.1097/00007691-197901030-00009. [DOI] [PubMed] [Google Scholar]
- Maguire J. H., Wilson D. C. Urinary dihydrodiol metabolites of phenytoin: high-performance liquid chromatographic assay of diastereomeric composition. J Chromatogr. 1985 Aug 9;342(2):323–332. doi: 10.1016/s0378-4347(00)84523-5. [DOI] [PubMed] [Google Scholar]
- Martz F., Failinger C., 3rd, Blake D. A. Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue. J Pharmacol Exp Ther. 1977 Oct;203(1):231–239. [PubMed] [Google Scholar]
- McClanahan J. S., Maguire J. H. High-performance liquid chromatographic determination of the enantiomeric composition of urinary phenolic metabolites of phenytoin. J Chromatogr. 1986 Sep 5;381(2):438–446. doi: 10.1016/s0378-4347(00)83612-9. [DOI] [PubMed] [Google Scholar]
- Seidegård J., De Pierre J. W., Birberg W., Pilotti A., Pero R. W. Characterization of soluble glutathione transferase activity in resting mononuclear leukocytes from human blood. Biochem Pharmacol. 1984 Oct 1;33(19):3053–3058. doi: 10.1016/0006-2952(84)90608-7. [DOI] [PubMed] [Google Scholar]
- Seidegård J., DePierre J. W., Pero R. W. Hereditary interindividual differences in the glutathione transferase activity towards trans-stilbene oxide in resting human mononuclear leukocytes are due to a particular isozyme(s). Carcinogenesis. 1985 Aug;6(8):1211–1216. doi: 10.1093/carcin/6.8.1211. [DOI] [PubMed] [Google Scholar]
- Seidegård J., DePierre J. W., Pero R. W. Measurement and characterization of membrane-bound and soluble epoxide hydrolase activities in resting mononuclear leukocytes from human blood. Cancer Res. 1984 Sep;44(9):3654–3660. [PubMed] [Google Scholar]
- Spielberg S. P., Gordon G. B., Blake D. A., Goldstein D. A., Herlong H. F. Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med. 1981 Sep 24;305(13):722–727. doi: 10.1056/NEJM198109243051302. [DOI] [PubMed] [Google Scholar]
- Spielberg S. P., Gordon G. B., Blake D. A., Mellits E. D., Bross D. S. Anticonvulsant toxicity in vitro: possible role of arene oxides. J Pharmacol Exp Ther. 1981 May;217(2):386–389. [PubMed] [Google Scholar]